Artemotil, also known as ?-arteether, is a semi-synthetic derivative of artemisinin and a fast acting blood schizonticide specifically indicated for the treatment of chloroquine-resistant Plasmodium falciparum malaria and cerebral malaria cases.
Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Artemether | The risk or severity of QTc prolongation can be increased when Artemotil is combined with Artemether. |
| Lumefantrine | The risk or severity of QTc prolongation can be increased when Artemotil is combined with Lumefantrine. |
| Thiethylperazine | The risk or severity of QTc prolongation can be increased when Artemotil is combined with Thiethylperazine. |
| Promazine | The risk or severity of QTc prolongation can be increased when Artemotil is combined with Promazine. |
| Prochlorperazine | The risk or severity of QTc prolongation can be increased when Artemotil is combined with Prochlorperazine. |
| Chlorpromazine | The risk or severity of QTc prolongation can be increased when Artemotil is combined with Chlorpromazine. |
| Triflupromazine | The risk or severity of QTc prolongation can be increased when Artemotil is combined with Triflupromazine. |
| Fluphenazine | The risk or severity of QTc prolongation can be increased when Artemotil is combined with Fluphenazine. |
| Thioridazine | The risk or severity of QTc prolongation can be increased when Artemotil is combined with Thioridazine. |
| Moricizine | The risk or severity of QTc prolongation can be increased when Artemotil is combined with Moricizine. |
| Trifluoperazine | The risk or severity of QTc prolongation can be increased when Artemotil is combined with Trifluoperazine. |
| Perphenazine | The risk or severity of QTc prolongation can be increased when Artemotil is combined with Perphenazine. |
| Mesoridazine | The risk or severity of QTc prolongation can be increased when Artemotil is combined with Mesoridazine. |
| Acetophenazine | The risk or severity of QTc prolongation can be increased when Artemotil is combined with Acetophenazine. |
| Promethazine | The risk or severity of QTc prolongation can be increased when Artemotil is combined with Promethazine. |
| Alimemazine | The risk or severity of QTc prolongation can be increased when Artemotil is combined with Alimemazine. |
| Methotrimeprazine | The risk or severity of QTc prolongation can be increased when Artemotil is combined with Methotrimeprazine. |
| Periciazine | The risk or severity of QTc prolongation can be increased when Artemotil is combined with Periciazine. |
| Acepromazine | The risk or severity of QTc prolongation can be increased when Artemotil is combined with Acepromazine. |
| Aceprometazine | The risk or severity of QTc prolongation can be increased when Artemotil is combined with Aceprometazine. |
| Pipotiazine | The risk or severity of QTc prolongation can be increased when Artemotil is combined with Pipotiazine. |
| Thioproperazine | The risk or severity of QTc prolongation can be increased when Artemotil is combined with Thioproperazine. |
| BL-1020 | The risk or severity of QTc prolongation can be increased when Artemotil is combined with BL-1020. |
| Cyamemazine | The risk or severity of QTc prolongation can be increased when Artemotil is combined with Cyamemazine. |
| Methylene blue | The risk or severity of QTc prolongation can be increased when Artemotil is combined with Methylene blue. |
| Propiopromazine | The risk or severity of QTc prolongation can be increased when Artemotil is combined with Propiopromazine. |
| Perazine | The risk or severity of QTc prolongation can be increased when Artemotil is combined with Perazine. |
| Butaperazine | The risk or severity of QTc prolongation can be increased when Artemotil is combined with Butaperazine. |
| Chlorproethazine | The risk or severity of QTc prolongation can be increased when Artemotil is combined with Chlorproethazine. |
| Thiazinam | The risk or severity of QTc prolongation can be increased when Artemotil is combined with Thiazinam. |
| Dixyrazine | The risk or severity of QTc prolongation can be increased when Artemotil is combined with Dixyrazine. |
| Perphenazine enanthate | The risk or severity of QTc prolongation can be increased when Artemotil is combined with Perphenazine enanthate. |
| Dapsone | The risk or severity of adverse effects can be increased when Artemotil is combined with Dapsone. |
| Vemurafenib | The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Artemotil. |
| Mefloquine | Mefloquine may increase the QTc-prolonging activities of Artemotil. |
| Lidocaine | The risk or severity of methemoglobinemia can be increased when Artemotil is combined with Lidocaine. |
| Ropivacaine | The risk or severity of methemoglobinemia can be increased when Artemotil is combined with Ropivacaine. |
| Bupivacaine | The risk or severity of methemoglobinemia can be increased when Artemotil is combined with Bupivacaine. |
| Cinchocaine | The risk or severity of methemoglobinemia can be increased when Artemotil is combined with Cinchocaine. |
| Dyclonine | The risk or severity of methemoglobinemia can be increased when Artemotil is combined with Dyclonine. |
| Procaine | The risk or severity of methemoglobinemia can be increased when Artemotil is combined with Procaine. |
| Prilocaine | The risk or severity of methemoglobinemia can be increased when Artemotil is combined with Prilocaine. |
| Proparacaine | The risk or severity of methemoglobinemia can be increased when Artemotil is combined with Proparacaine. |
| Meloxicam | The risk or severity of methemoglobinemia can be increased when Artemotil is combined with Meloxicam. |
| Oxybuprocaine | The risk or severity of methemoglobinemia can be increased when Artemotil is combined with Oxybuprocaine. |
| Cocaine | The risk or severity of methemoglobinemia can be increased when Artemotil is combined with Cocaine. |
| Mepivacaine | The risk or severity of methemoglobinemia can be increased when Artemotil is combined with Mepivacaine. |
| Levobupivacaine | The risk or severity of methemoglobinemia can be increased when Artemotil is combined with Levobupivacaine. |
| Diphenhydramine | The risk or severity of methemoglobinemia can be increased when Artemotil is combined with Diphenhydramine. |
| Benzocaine | The risk or severity of methemoglobinemia can be increased when Artemotil is combined with Benzocaine. |
| Chloroprocaine | The risk or severity of methemoglobinemia can be increased when Artemotil is combined with Chloroprocaine. |
| Phenol | The risk or severity of methemoglobinemia can be increased when Artemotil is combined with Phenol. |
| Tetrodotoxin | The risk or severity of methemoglobinemia can be increased when Artemotil is combined with Tetrodotoxin. |
| Benzyl alcohol | The risk or severity of methemoglobinemia can be increased when Artemotil is combined with Benzyl alcohol. |
| Capsaicin | The risk or severity of methemoglobinemia can be increased when Artemotil is combined with Capsaicin. |
| Etidocaine | The risk or severity of methemoglobinemia can be increased when Artemotil is combined with Etidocaine. |
| Articaine | The risk or severity of methemoglobinemia can be increased when Artemotil is combined with Articaine. |
| Tetracaine | The risk or severity of methemoglobinemia can be increased when Artemotil is combined with Tetracaine. |
| Propoxycaine | The risk or severity of methemoglobinemia can be increased when Artemotil is combined with Propoxycaine. |
| Pramocaine | The risk or severity of methemoglobinemia can be increased when Artemotil is combined with Pramocaine. |
| Butamben | The risk or severity of methemoglobinemia can be increased when Artemotil is combined with Butamben. |
| Butacaine | The risk or severity of methemoglobinemia can be increased when Artemotil is combined with Butacaine. |
| Oxetacaine | The risk or severity of methemoglobinemia can be increased when Artemotil is combined with Oxetacaine. |
| Ethyl chloride | The risk or severity of methemoglobinemia can be increased when Artemotil is combined with Ethyl chloride. |
| Butanilicaine | The risk or severity of methemoglobinemia can be increased when Artemotil is combined with Butanilicaine. |
| Metabutethamine | The risk or severity of methemoglobinemia can be increased when Artemotil is combined with Metabutethamine. |
| Quinisocaine | The risk or severity of methemoglobinemia can be increased when Artemotil is combined with Quinisocaine. |
| Ambroxol | The risk or severity of methemoglobinemia can be increased when Artemotil is combined with Ambroxol. |